Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Antikörper:
anti-Rat (Rattus) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal SPR Primary Antibody für WB - ABIN520456
Lange, Geerts, Feith, Mocz, Koster, Bachmann: Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. in Journal of molecular biology 2014
Human Polyclonal SPR Primary Antibody für ELISA, WB - ABIN562987
Balasubramanian, Deng, Doudney, Hampton, Kennedy: Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line. in Neuropharmacology 2015
Human Polyclonal SPR Primary Antibody für WB - ABIN653908
Maddens, Ghesquière, Vanholder, Demon, Vanmassenhove, Gevaert, Meyer: Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury. in Molecular & cellular proteomics : MCP 2012
The allele frequencies for the SPR c.596-2A > G (0.7%) polymorphism is not a major cause of Parkinson's disease in the Maltese.
We earlier presented evidence for a physical interaction between ODC (zeige ODC1 Antikörper) and SPR and we showed that RNAi-mediated knockdown of SPR expression significantly reduced native ODC (zeige ODC1 Antikörper) enzyme activity and impeded Neuroblastoma (zeige ARHGEF16 Antikörper) cell proliferation.
new homozygous mutation in the SPR gene was found in two sisters with dopa-responsive dystonia
Authors identified SPR as a novel regulator of ODC (zeige ODC1 Antikörper) enzyme activity and, based on clinical evidence, present a model in which SPR drives ODC (zeige ODC1 Antikörper)-mediated malignant progression in neuroblastoma (zeige ARHGEF16 Antikörper).
SPR-mediated reduction of sepiapterin and redox cycling occur by distinct mechanisms
this large association study for the SPR gene revealed no association for Parkinson disease worldwide.
We examine the sleep, sleep-wake rhythms, CSF (zeige CSF2 Antikörper) neurotransmitters, and melatonin profile in a patient with sepiapterin reductase deficiency.
haploinsufficiency of SPR can be a rare cause of dopa-responsive dystonia
Although association of SPR to Parkinson's disease (PD) is not strong enough to support that this is the PARK3 gene, this study further implicates a role for SPR in idiopathic PD.
Genomic DNA revealed the same homozygous point mutation introducing a premature stop codon in the SPR gene in 2 siblings.
Our results suggest that the hypertension with fluctuation and bradycardia of Spr(-/-) mice would be caused by an imbalance of sympathetic and parasympathetic input and impaired nitric oxide production in endothelial cells.
biopterin contents in the brains of these knock-out mice were moderately decreased from postnatal day 0 (P0) and remained constant up to P21 (zeige D4S234E Antikörper)
These data suggest an essential role of SPR in the biosynthesis of BH4, and that the SPR gene could be a candidate gene for PARK3.
this study demonstrates an important role of endothelial SPR in modulating tetrahydrobiopterin and nitric oxide bioavailability
This gene encodes an aldo-keto reductase that catalyzes the NADPH-dependent reduction of pteridine derivatives and is important in the biosynthesis of tetrahydrobiopterin (BH4). Mutations in this gene result in DOPA-responsive dystonia due to sepiaterin reductase deficiency. A pseudogene has been identified on chromosome 1.
, short chain dehydrogenase/reductase family 38C, member 1
, 7,8-dihydrobiopterin:NADP+ oxidoreductase
, Sepiapterin reductase
, sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)